West Syndrome Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: W529838A94C5EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of West Syndrome in Global, including the following market information:

Global West Syndrome Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global West Syndrome market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the West Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global West Syndrome Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global West Syndrome Market Segment Percentages, By Type, 2020 (%)

• Treatment Practices
• Emerging Drugs

China West Syndrome Market, By Application, 2016-2021, 2022-2027 ($ millions)

China West Syndrome Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic
• Others

Global West Syndrome Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global West Syndrome Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total West Syndrome Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total West Syndrome Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• GW Pharmaceuticals
• Lundbeck
• Mallinckrodt Pharmaceuticals
• INSYS Therapeutics
• Questcor Pharmaceuticals
• BioPharm Solutions

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Deep Brain Stimulation in Parkinson's Disease Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Deep Brain Stimulation in Parkinson's Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE OVERALL MARKET SIZE

2.1 Global Deep Brain Stimulation in Parkinson's Disease Market Size: 2021 VS 2027
2.2 Global Deep Brain Stimulation in Parkinson's Disease Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Deep Brain Stimulation in Parkinson's Disease Players in Global Market
3.2 Top Global Deep Brain Stimulation in Parkinson's Disease Companies Ranked by Revenue
3.3 Global Deep Brain Stimulation in Parkinson's Disease Revenue by Companies
3.4 Top 3 and Top 5 Deep Brain Stimulation in Parkinson's Disease Companies in Global Market, by Revenue in 2020
3.5 Global Companies Deep Brain Stimulation in Parkinson's Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Deep Brain Stimulation in Parkinson's Disease Players in Global Market
  3.6.1 List of Global Tier 1 Deep Brain Stimulation in Parkinson's Disease Companies
  3.6.2 List of Global Tier 2 and Tier 3 Deep Brain Stimulation in Parkinson's Disease Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Deep Brain Stimulation in Parkinson's Disease Market Size Markets, 2021 & 2027
  4.1.2 Dual Channel Deep brain Stimulator
  4.1.3 Single Channel Deep brain Stimulator
4.2 By Type - Global Deep Brain Stimulation in Parkinson's Disease Revenue & Forecasts
  4.2.1 By Type - Global Deep Brain Stimulation in Parkinson's Disease Revenue, 2016-2021
  4.2.2 By Type - Global Deep Brain Stimulation in Parkinson's Disease Revenue, 2022-2027
  4.2.3 By Type - Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Deep Brain Stimulation in Parkinson's Disease Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Neurology Clinics
  5.1.4 Research Centers
5.2 By Application - Global Deep Brain Stimulation in Parkinson's Disease Revenue & Forecasts
  5.2.1 By Application - Global Deep Brain Stimulation in Parkinson's Disease Revenue, 2016-2021
  5.2.2 By Application - Global Deep Brain Stimulation in Parkinson's Disease Revenue, 2022-2027
  5.2.3 By Application - Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Deep Brain Stimulation in Parkinson's Disease Market Size, 2021 & 2027
6.2 By Region - Global Deep Brain Stimulation in Parkinson's Disease Revenue & Forecasts
  6.2.1 By Region - Global Deep Brain Stimulation in Parkinson's Disease Revenue, 2016-2021
  6.2.2 By Region - Global Deep Brain Stimulation in Parkinson's Disease Revenue, 2022-2027
  6.2.3 By Region - Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Deep Brain Stimulation in Parkinson's Disease Revenue, 2016-2027
  6.3.2 US Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.3.3 Canada Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.3.4 Mexico Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Deep Brain Stimulation in Parkinson's Disease Revenue, 2016-2027
  6.4.2 Germany Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.4.3 France Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.4.4 U.K. Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.4.5 Italy Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.4.6 Russia Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.4.7 Nordic Countries Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.4.8 Benelux Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Deep Brain Stimulation in Parkinson's Disease Revenue, 2016-2027
  6.5.2 China Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.5.3 Japan Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.5.4 South Korea Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.5.5 Southeast Asia Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.5.6 India Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Deep Brain Stimulation in Parkinson's Disease Revenue, 2016-2027
  6.6.2 Brazil Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.6.3 Argentina Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Revenue, 2016-2027
  6.7.2 Turkey Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.7.3 Israel Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.7.4 Saudi Arabia Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027
  6.7.5 UAE Deep Brain Stimulation in Parkinson's Disease Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Deep Brain Stimulation in Parkinson's Disease Major Product Offerings
  7.1.4 Abbott Deep Brain Stimulation in Parkinson's Disease Revenue in Global (2016-2021)
  7.1.5 Abbott Key News
7.2 Aleva Neurotherapeutics SA
  7.2.1 Aleva Neurotherapeutics SA Corporate Summary
  7.2.2 Aleva Neurotherapeutics SA Business Overview
  7.2.3 Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Major Product Offerings
  7.2.4 Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Revenue in Global (2016-2021)
  7.2.5 Aleva Neurotherapeutics SA Key News
7.3 Beijing PINS Medical Co
  7.3.1 Beijing PINS Medical Co Corporate Summary
  7.3.2 Beijing PINS Medical Co Business Overview
  7.3.3 Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Major Product Offerings
  7.3.4 Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Revenue in Global (2016-2021)
  7.3.5 Beijing PINS Medical Co Key News
7.4 Boston Scientific Corporation
  7.4.1 Boston Scientific Corporation Corporate Summary
  7.4.2 Boston Scientific Corporation Business Overview
  7.4.3 Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Major Product Offerings
  7.4.4 Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Revenue in Global (2016-2021)
  7.4.5 Boston Scientific Corporation Key News
7.5 Functional Neuromodulation Ltd
  7.5.1 Functional Neuromodulation Ltd Corporate Summary
  7.5.2 Functional Neuromodulation Ltd Business Overview
  7.5.3 Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Major Product Offerings
  7.5.4 Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Revenue in Global (2016-2021)
  7.5.5 Functional Neuromodulation Ltd Key News
7.6 Medtronic
  7.6.1 Medtronic Corporate Summary
  7.6.2 Medtronic Business Overview
  7.6.3 Medtronic Deep Brain Stimulation in Parkinson's Disease Major Product Offerings
  7.6.4 Medtronic Deep Brain Stimulation in Parkinson's Disease Revenue in Global (2016-2021)
  7.6.5 Medtronic Key News
7.7 Neuronetics Inc.
  7.7.1 Neuronetics Inc. Corporate Summary
  7.7.2 Neuronetics Inc. Business Overview
  7.7.3 Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Major Product Offerings
  7.4.4 Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Revenue in Global (2016-2021)
  7.7.5 Neuronetics Inc. Key News
7.8 NeuroPace Inc.
  7.8.1 NeuroPace Inc. Corporate Summary
  7.8.2 NeuroPace Inc. Business Overview
  7.8.3 NeuroPace Inc. Deep Brain Stimulation in Parkinson's Disease Major Product Offerings
  7.8.4 NeuroPace Inc. Deep Brain Stimulation in Parkinson's Disease Revenue in Global (2016-2021)
  7.8.5 NeuroPace Inc. Key News
7.9 Nevro Corporation
  7.9.1 Nevro Corporation Corporate Summary
  7.9.2 Nevro Corporation Business Overview
  7.9.3 Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Major Product Offerings
  7.9.4 Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Revenue in Global (2016-2021)
  7.9.5 Nevro Corporation Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. West Syndrome Market Opportunities & Trends in Global Market
Table 2. West Syndrome Market Drivers in Global Market
Table 3. West Syndrome Market Restraints in Global Market
Table 4. Key Players of West Syndrome in Global Market
Table 5. Top West Syndrome Players in Global Market, Ranking by Revenue (2019)
Table 6. Global West Syndrome Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global West Syndrome Revenue Share by Companies, 2016-2021
Table 8. Global Companies West Syndrome Product Type
Table 9. List of Global Tier 1 West Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 West Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global West Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - West Syndrome Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - West Syndrome Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global West Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - West Syndrome Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - West Syndrome Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global West Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global West Syndrome Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global West Syndrome Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America West Syndrome Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America West Syndrome Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe West Syndrome Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe West Syndrome Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia West Syndrome Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia West Syndrome Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America West Syndrome Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America West Syndrome Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa West Syndrome Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa West Syndrome Revenue, (US$, Mn), 2022-2027
Table 30. GW Pharmaceuticals Corporate Summary
Table 31. GW Pharmaceuticals West Syndrome Product Offerings
Table 32. GW Pharmaceuticals West Syndrome Revenue (US$, Mn), (2016-2021)
Table 33. Lundbeck Corporate Summary
Table 34. Lundbeck West Syndrome Product Offerings
Table 35. Lundbeck West Syndrome Revenue (US$, Mn), (2016-2021)
Table 36. Mallinckrodt Pharmaceuticals Corporate Summary
Table 37. Mallinckrodt Pharmaceuticals West Syndrome Product Offerings
Table 38. Mallinckrodt Pharmaceuticals West Syndrome Revenue (US$, Mn), (2016-2021)
Table 39. INSYS Therapeutics Corporate Summary
Table 40. INSYS Therapeutics West Syndrome Product Offerings
Table 41. INSYS Therapeutics West Syndrome Revenue (US$, Mn), (2016-2021)
Table 42. Questcor Pharmaceuticals Corporate Summary
Table 43. Questcor Pharmaceuticals West Syndrome Product Offerings
Table 44. Questcor Pharmaceuticals West Syndrome Revenue (US$, Mn), (2016-2021)
Table 45. BioPharm Solutions Corporate Summary
Table 46. BioPharm Solutions West Syndrome Product Offerings
Table 47. BioPharm Solutions West Syndrome Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. West Syndrome Segment by Type
Figure 2. West Syndrome Segment by Application
Figure 3. Global West Syndrome Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global West Syndrome Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global West Syndrome Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by West Syndrome Revenue in 2020
Figure 8. By Type - Global West Syndrome Revenue Market Share, 2016-2027
Figure 9. By Application - Global West Syndrome Revenue Market Share, 2016-2027
Figure 10. By Region - Global West Syndrome Revenue Market Share, 2016-2027
Figure 11. By Country - North America West Syndrome Revenue Market Share, 2016-2027
Figure 12. US West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 13. Canada West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe West Syndrome Revenue Market Share, 2016-2027
Figure 16. Germany West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 17. France West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 19. Italy West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 20. Russia West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia West Syndrome Revenue Market Share, 2016-2027
Figure 24. China West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 25. Japan West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 28. India West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America West Syndrome Revenue Market Share, 2016-2027
Figure 30. Brazil West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa West Syndrome Revenue Market Share, 2016-2027
Figure 33. Turkey West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 34. Israel West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 36. UAE West Syndrome Revenue, (US$, Mn), 2016-2027
Figure 37. GW Pharmaceuticals West Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Lundbeck West Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Mallinckrodt Pharmaceuticals West Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. INSYS Therapeutics West Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Questcor Pharmaceuticals West Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)